HAIFA, Israel, Sept. 24, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), today announced the closing of the exercise in full of the underwriters' option to purchase an additional 1,200,000 shares of common stock of the company. As previously announced, as part of the firm commitment underwritten public offering that was closed on September 19, 2012, the company granted the underwriters a 30-day option to purchase up to 1,200,000 shares of common stock and/or warrants to purchase up to 420,000 shares of common stock. The underwriters previously exercised their option to purchase 1,200,000 warrants to purchase up to 420,000 of the company's common stock at an exercise price of $5.00 per share, at a purchase price of $0.0094 per warrant and have now also exercised their option to purchase 1,200,000 shares of common stock at $3.7506 per share. The gross proceeds to the company as a result of the exercise of this option are approximately $4.5 million.
Pluristem Announces Closing Of Underwriters' Option To Purchase Additional Common Stock
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts